CRA II – UK National Monitoring
Our Clinical Operations department in the UK is looking for a CRA II to work across a variety of therapeutic areas – including Oncology. You can be based anywhere in the UK, but previous UK monitoring experience is required.
The role in summary:
National monitoring across the UK
Oncology trials will include various solid tumor studies: Prostate, NSCLC, Leukemia, Breast, Glioblastoma, and studies in Hematological Malignancies
Other TAs include Neuroscience, Cell/Gene therapies, Respiratory, Cardiovascular, Infectious Disease, Nephrology, Endocrinology & Gastroenterology
On average each CRA II will work across 5 protocols or more
Risk-based monitoring model
Approximately 8 days on site per month or more
Join a fast-paced global CRO that combines innovation with 30 years of expertise, offering personalized development plans and career progression. Work in a supportive environment with flexible Line Managers, gain diverse experience through collaborations with smaller biotech and biopharma pioneers and contribute to cutting-edge therapies.
Learn more about our EEO & Accommodations request here.
